Evolution of the Average Target: Copart, Inc.

Evolution of the Target Price: Copart, Inc.

Changes in Analyst Recommendations: Copart, Inc.

514e1c71ed911.jO4p8HRbL-TH_yLlPkKAL6fbuINXVcywuH4DZizGmHc.z4JGg0wdbZSAjHGTVCX5e5ed09VgAKHn-zVSARSsoDXNmHCKTDNdu6PKEg~94dc44aa2105f5c18e58730774afa40c
09-11 Barrington Upgrades Copart to Outperform From Market Perform, Price Target is $40 MT
09-03 Copart Shares Rise After JPMorgan Upgrade MT
09-03 Wall Street's Triple Squeeze Zonebourse
09-03 JPMorgan Upgrades Copart to Overweight From Neutral, Adjusts Price Target to $40 From $32 MT
09-03 Analyst recommendations: Copart, Moderna, Broadcom, DuPont de Nemours… Zonebourse
08-26 U.S. research roundup- Intuit, MongoDB, Zscaler RE
08-25 Barclays Adjusts Price Target on Copart to $25 From $26 MT
07-21 Barclays Adjusts Price Target on Copart to $26 From $32, Maintains Underweight Rating MT
07-07 JPMorgan Adjusts Price Target on Copart to $32 From $35 MT
05-26 Stephens Adjusts Copart Price Target to $35 From $33, Maintains Equal Weight Rating MT
05-22 BNP Paribas Adjusts Copart Price Target to $40 From $44, Maintains Outperform Rating MT
05-22 Baird Adjusts Price Target on Copart to $42 From $48, Maintains Outperform Rating MT
05-22 JPMorgan Adjusts Price Target on Copart to $35 From $34, Maintains Neutral Rating MT
05-15 Stephens Adjusts Copart Price Target to $33 From $35, Maintains Equal Weight Rating MT
02-23 JPMorgan Adjusts Price Target on Copart to $34 From $45, Maintains Neutral Rating MT
02-20 Jefferies Adjusts Price Target on Copart to $47 From $50, Maintains Buy Rating MT
02-20 Baird Adjusts Price Target on Copart to $48 From $52, Maintains Outperform Rating MT
02-20 BNP Paribas Adjusts Price Target on Copart to $44 From $47, Maintains Outperform Rating MT
02-20 Barclays Adjusts Price Target on Copart to $32 From $33, Maintains Underweight Rating MT
12-18 BMO Keeps RB Global's Outperform Rating, US$130 Price Target MT
12-02 Stephens Adjusts Price Target on Copart to $39 From $46, Maintains Equalweight Rating MT
11-24 JPMorgan Adjusts Price Target on Copart to $45 From $50, Maintains Neutral Rating MT
11-21 BNP Paribas Exane Adjusts Price Target on Copart to $47 From $58 MT
11-21 Baird Adjusts Price Target on Copart to $52 From $55, Maintains Outperform Rating MT
11-21 Barclays Adjusts Price Target on Copart to $33 From $32, Maintains Underweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+70.2%
+28.4%
+45.13%
+19.19%
+47.06%
+6.64%
+25.12%
+53.08%
+35.63%
Average +36.72%
Weighted average by Cap. +44.07%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
31.73USD
Average target price
39.70USD
Spread / Average Target
+25.12%
High Price Target
55.00USD
Spread / Highest target
+73.34%
Low Price Target
25.00USD
Spread / Lowest Target
-21.21%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!